Renteria traded to Braves

Red Sox acquire third base prospect Marte in return

Tigers add Rogers, closer Jones

December 09, 2005

Baseball executives finished the winter meetings with a flurry of deals before heading home, with the Boston Red Sox giving up on shortstop Edgar Renteria and the Detroit Tigers adding pitchers Kenny Rogers and Todd Jones.

On the fourth and final day of the busiest winter meetings in years, Boston sent Renteria to the Atlanta Braves for third base prospect Andy Marte.

Renteria won Gold Gloves in 2002 and 2003, then helped St. Louis win the National League pennant in 2004. He signed a four-year, $40 million deal with the Red Sox but led the major leagues with 30 errors last season.

Boston agreed to pay $8 million of the $26 million he is owed in the next three seasons - plus the $3 million buyout if his 2009 option is declined.

"We looked at his time in the National League and we believe that when he gets back to the National League in Atlanta, he will return to the Renteria of old," Atlanta general manager John Schuerholz said.

Detroit was busy, agreeing to a two-year, $16 million contract with left-hander Rogers and a two-year, $11 million deal with closer Jones. The Tigers announced Jones' contract but didn't confirm Rogers' agreement.

Rogers was 14-8 with a 3.46 ERA with the Texas Rangers but will be most remembered for a videotaped tirade June 29 in which he shoved two television cameramen while walking onto the field. He was suspended for 20 games, a penalty he appealed and had reduced to 13 games.

Jones was 1-5 with a 2.10 ERA and 40 saves last season for the Florida Marlins, his sixth team since leaving Detroit.

In other news, the New York Yankees gave up on second baseman Tony Womack, who lost his starting job a month into last season after hitting .307 as Renteria's St. Louis teammate in 2004. Womack went to the Reds yesterday for infielder Kevin Howard and outfielder Ben Himes in the trade; New York sent $900,000 to the Reds to offset part of Womack's $2 million salary next season.

New York also reached a preliminary agreement on a two-year, $2.4 million contract with lefty reliever Mike Myers, who was 3-1 with a 3.13 ERA in 65 games last season as Boston's left-handed specialist.

There were more than a dozen trades and 20 free-agent signings at the meetings.

In other free-agent news, Colorado agreed to a one-year, $2.5 million deal with reliever Jose Mesa, the Kansas City Royals agreed to a two-year contract with pitcher Elmer Dessens and infielder Jose Valentin agreed to a one-year contract with the New York Mets worth $912,500.

First-baseman outfielder Mark Sweeney got a two-year, $1.8 million contract with the San Francisco Giants, and outfielder Orlando Palmeiro stayed with the Houston Astros for $1.9 million over two years.

Steroids -- Major league baseball players made it official, unanimously approving a new steroid agreement that toughens penalties and could result in a lifetime ban for a third offense. The player's association executive board, as expected, approved the deal worked out with management Nov. 15 under the threat of even tougher legislation from Congress. Union head Donald Fehr said yesterday there was no need for all players to vote on the agreement because there were no real objections. "We discussed it so much with the players that there is no need for it," Fehr said. "The executive board has the authority, anyway." The approval came during the annual executive board meeting of the union, attended by 45-50 board members at a resort outside Las Vegas. Baseball owners approved the same deal last month, and the union's acceptance formalizes the pact reached in earlier negotiations. Under the agreement, players will be suspended 50 games without pay for a first offense and 100 for a second offense. A third positive test would result in a lifetime ban. The sport's current penalties are a 10-day suspension for a first offense, 30 days for a second offense and 60 days for a third.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.